Remembering Jeff A. Sloan, PhD

May 4, 2022

Dear Alliance Colleagues and Friends,

I am so sad to inform you that Jeff A. Sloan, PhD, passed away this week. He had been in ill health due to cancer for quite some time and passed away peacefully on May 1st with his family at his side. At the time of his death, Jeff was Professor of Biostatistics and Oncology at the Mayo Clinic in Rochester, Minnesota, a position that he held since 1995. Jeff was trained as a mathematical statistician,

New Trial Alert: Alliance A022102 Gastroesophageal Cancer

January 12, 2023

Alliance A022102: A randomized phase III trial of mFOLFIRINOX +/- nivolumab vs. FOLFOX +/- nivolumab for first-line treatment of metastatic HER2-negative gastroesophageal adenocarcinoma

Haeseong Park, MD, MPH, of Dana-Farber Cancer Institute, leads Alliance A022102 – a phase III trial that compares the effect of modified fluorouracil, leucovorin calcium, oxaliplatin, and irinotecan (mFOLFIRINOX) to mo

New Trial Alert: Alliance A022101 Limited Metastatic Colorectal Cancer

January 11, 2023

Alliance A022101: A pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer: evaluating radiation, ablation, and surgery (ERASur)

Eric D. Miller, MD, PhD, of Ohio State University Medical Center, leads Alliance A022101 (ERASur) – a phase III trial that compares total ablative therapy and usual systemic therapy to usual

Older News